GHRP-2 Reconstitution Guide
Part of the full GHRP-2 guide - a synthetic hexapeptide growth hormone secretagogue reference compound, identity-verified with a COA on every vial.
In brief
Laboratory handling of GHRP-2 begins with reconstitution because the peptide is supplied as a lyophilized (freeze-dried) solid and must be brought into solution before any in-vitro work. This section describes the bacteriostatic-water reconstitution principle and the concentration arithmetic a researcher uses to convert a known mass of lyophilized peptide into a defined working stock for benchtop assays. It is strictly a laboratory preparation account: there is no human dosing protocol here, only the chemistry of dissolving a measured powder into a measured solvent volume and storing the resulting solution for cell-based or receptor-binding experiments. The molecular weight of 817.99 g/mol for the free peptide is the anchor value for any molar-concentration calculation. All steps below assume sterile technique, appropriate labware, and that the material is destined for in-vitro research use only.
The detail
A closer look
01
The bacteriostatic-water reconstitution principle
Lyophilized GHRP-2 is reconstituted by adding a sterile aqueous diluent to the vial so the powder dissolves into a homogeneous stock solution. Bacteriostatic water (water containing a small amount of preservative such as benzyl alcohol) is the conventional laboratory diluent because the preservative suppresses microbial growth, which matters for any stock that will be stored and sampled repeatedly over several days. The diluent is directed slowly down the vial wall rather than forcefully onto the lyophilized cake, because peptides are shear- and foam-sensitive; the vial is then left to dissolve with gentle swirling rather than vigorous shaking. The chosen diluent volume determines the final concentration, so it is selected deliberately before reconstitution rather than topped up afterward.
02
Concentration calculation using the molecular weight
Concentration is fixed by the mass of peptide in the vial divided by the diluent volume added. For a mass-per-volume figure, dividing the labeled peptide mass by the milliliters of bacteriostatic water gives milligrams per milliliter directly. To express the stock in molar terms for receptor-binding or signaling assays, the free-peptide molecular weight of 817.99 g/mol converts mass to moles: moles equal grams divided by 817.99, and molarity equals those moles divided by the solution volume in liters. Working stocks are typically diluted further into assay buffer or culture medium to reach the nanomolar-to-micromolar ranges used in GHS-R1a agonist pharmacology. Keeping the molecular weight explicit avoids errors when moving between mass-based and molar-based concentrations.
03
Storage and stability handling
Because GHRP-2 is a peptide, reconstituted stock is treated as a perishable biological reagent. The lyophilized powder is the most stable form and is generally kept cold and desiccated until use. Once in solution, the stock is stored refrigerated for short-term use and frozen for longer-term holding, with aliquoting recommended so that the working solution is not subjected to repeated freeze-thaw cycles that can degrade peptide integrity. Vials are labeled with peptide identity, concentration, diluent, and date. Solutions are inspected for clarity before use, and any cloudiness or particulate is grounds for discarding the stock. These handling practices preserve the molecule for the in-vitro receptor and cell assays it is intended for.
Step by step
How GHRP-2 is reconstituted
A bench reference for handling and preparation in an in-vitro research setting. Not a personal dosing protocol.
- 1
Confirm the labeled peptide mass on the vial and decide the target stock concentration before opening, since the diluent volume you choose sets the final concentration.
- 2
Calculate the bacteriostatic-water volume required: divide the labeled peptide mass by your desired mg/mL concentration to get the milliliters of diluent to add.
- 3
For molar stocks, convert using the free-peptide molecular weight of 817.99 g/mol (moles = grams / 817.99; molarity = moles / liters of solution).
- 4
Wipe the vial septum with an alcohol wipe and draw the calculated volume of sterile bacteriostatic water into a syringe using aseptic technique.
- 5
Add the diluent slowly down the inner vial wall rather than directly onto the lyophilized cake to minimize shear and foaming.
- 6
Let the vial stand and dissolve with gentle swirling; do not shake vigorously. The solution should be clear before use.
- 7
Label the reconstituted vial with peptide identity, final concentration, diluent, and date.
- 8
Store refrigerated for short-term in-vitro use; for longer-term storage, aliquot and freeze to avoid repeated freeze-thaw cycles.
- 9
Before each experiment, inspect the stock for clarity and discard if any cloudiness or particulate is present.
The fine print: products are sold for laboratory research use only and are not for human or animal consumption. Bodily introduction into humans or animals is strictly prohibited by law. GHRP-2 is not a drug and is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA.